MENU

Research

The Division of Infectious Diseases and Tropical Travel Clinic at East Carolina University is involved in clinical and translational research. Research and clinical trial areas include HIV/AIDs, TB, and Hepatitis.

Through new discoveries in the research we strive to improve the quality of care for our patient population. Our research and clinical trials have allowed us to escalate our knowledge and patient care.

Current Projects

Study: Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women (WAVES) View PDF
Director: Huyen Cao, MD
Status: This study is ongoing, but not recruiting participants.

Study: Prospective Observational Epidemiologic Study of Maraviroc's Safety (POEM) View PDF
Director: Pfizer CT.gov Call Center
Status: This study is enrolling participants by invitation only.

Study: Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir View PDF
Director: Javier Szwarcberg, MD, MPH
Status: This study is ongoing, but not recruiting participants.

Study: Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced Adults View PDF
Director: Hal Martin, MD, MPH
Status: This study is currently recruiting participants.

Study: Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults View PDF
Director: Moupali Das, MD, MPH
Status: This study is ongoing, but not recruiting participants.

Study: Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults View PDF
Director: Huyen Cao, MD
Status: This study is ongoing, but not recruiting participants.

Study: Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects View PDF
Director: Scott McCallister, MD
Status: This study is ongoing, but not recruiting participants.